Baird Financial Group Inc. Makes New $2.19 Million Investment in Aspen Aerogels, Inc. $ASPN

Key Points

• Baird Financial Group initiated a $2.19 million position in Aspen Aerogels, buying 345,193 shares, while institutional investors collectively own 97.64% of the company.
• Analyst sentiment is mixed: four analysts rate the stock a “Buy,” one rates it “Hold,” and two rate it “Sell.” The consensus rating is “Hold,” with an average price target of $5.94.
• Aspen Aerogels reported quarterly revenue of $49.85 million, exceeding expectations, and an adjusted loss of $0.22 per share. The stock recently traded at $5.12, compared with a 52-week range of $2.30 to $9.35.

Baird Financial Group Inc. bought a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 345,193 shares of the construction company's stock, valued at approximately $2,189,000. Baird Financial Group Inc. owned 0.42% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Concurrent Investment Advisors LLC lifted its holdings in shares of Aspen Aerogels by 6.7% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company's stock valued at $203,000 after buying an additional 2,000 shares during the period. Headlands Technologies LLC acquired a new position in Aspen Aerogels during the second quarter worth $174,000. Equitable Holdings Inc. acquired a new position in Aspen Aerogels during the second quarter worth $88,000. Jefferies Financial Group Inc. purchased a new position in Aspen Aerogels in the second quarter worth $801,000. Finally, Public Employees Retirement System of Ohio purchased a new position in Aspen Aerogels in the second quarter worth $812,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

ASPN has been the topic of several research analyst reports. B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Wall Street Zen downgraded shares of Aspen Aerogels from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Roth Capital reiterated a "buy" rating and issued a $7.75 price objective on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays raised their price objective on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research note on Tuesday, August 11th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels currently has an average rating of "Hold" and an average target price of $5.94.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $5.12 on Friday. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The company's 50-day moving average price is $5.17 and its 200 day moving average price is $4.80. Aspen Aerogels, Inc. has a 52 week low of $2.30 and a 52 week high of $9.35. The stock has a market cap of $425.32 million, a price-to-earnings ratio of -3.35 and a beta of 2.97.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The company had revenue of $49.85 million during the quarter, compared to analysts' expectations of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. As a group, research analysts forecast that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc is a technology company that develops, manufactures and sells advanced aerogel-based materials. Aerogels are highly porous materials designed to provide thermal insulation, fire protection and other performance benefits in applications where conventional insulation may be less effective or require more space.

The company serves the energy, industrial and automotive markets. Its products include thermal barriers for electric vehicle batteries, insulation materials for industrial and energy infrastructure, and specialty aerogel products used in applications involving heat management, fire mitigation and cryogenic or high-temperature environments.

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.